Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2008

View Archived Issues

SVV-001 studied in experimental medulloblastoma in mice

Renovo presents results from Juvista and Zesteem trials

Rigel presents preclinical data on novel JAK2 inhibitor R-723

Qnexa meets primary endpoint in 28-week EQUATE study

Xoma provides preclinical animal data for diabetes drug XOMA-052

Valeant to acquire Dow Pharmaceutical Sciences for USD 285 million

IDMC recommends continuation of Seattle Genetics' phase IIb trial of lintuzumab in AML

Pharmacokinetic data for retigabine therapy disclosed

Nile presents results from phase Ib safety and PK study of CD-NP

Nuvelo reports encouraging results from phase I NU-206 trial in healthy volunteers

Phase III data show paliperidone's efficacy and tolerability in schizophrenia

PolyMedix announces positive phase I PMX-30063 data

ZymoGenetics reports favorable phase IIIb Recothrom results

Amylin, Lilly and Alkermes present update on DURATION clinical program for Byetta

FDA approves Pegintron/Rebetol combination in pediatric HCV patients

German regulatory authority approves CureVac's CTA to initiate phase I clinical study of CV-9103

SkyePharma and Somnus successfully complete phase I trial of SKP-1041 for sleep maintenance

Affiris initiates preclinical development of Parkinson's vaccine PD-01

Galmed successfully completes phase I trial of aramchol for fatty liver disease

Santhera completes recruitment into phase III MICONOS trial of SNT-MC17

Responses seen with afutuzumab in patients with CD20+ non-Hodgkin's lymphoma

TG-101348 appears well tolerated, decreases spleen size in myelofibrosis patients

Abraxis BioScience launches Abraxane in the European Union

Novel therapeutic agents for GERD disclosed in recent AstraZeneca patent

New antidiabetic agents disclosed in recent Merck Frosst patent

Recent Roche patent reports new agents for obesity

Rigel presents clinical data on fostamatinib disodium in B-cell NHL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...